Shares in United Therapeutics (NSDQ:UTHR) fell today even though the biotech beat expectations on Wall Street with its second quarter results.
The company recorded a net loss for the quarter and revealed that it has set aside $210 million for a possible settlement with the Dept. of Justice, according to United’s quarterly regulatory filing.
Get the full story at our sister site, Drug Delivery Business News.
The post United Therapeutics logs Q2 beat appeared first on MassDevice.